论文部分内容阅读
保前列是从三种药用植物中提取、加工制成的,用来缓解良性前列腺增生症(BPH)症状的药物。为了验证其疗效及安全性,我们于1997年3月～5月对40例服用保前列的BPH患者进行了临床观察。现报告如下。 1 资料与方法 1.1 病例资料 全部病例均为门诊患者,年龄54岁～78岁(平均65岁)。治疗前均自诉有排尿困难,平均病程4.3a。所有患者均无其它严重疾病并未行特殊治疗。 1.2 方法 1.2.1 药物治疗方法 40例患者均口服保前列,qid,2片/次(0.25g/片),共服4周。分别于治疗前及治疗4周后进行临床及实验室检查。治疗期间记
Precursor is extracted from three kinds of medicinal plants, processed and used to relieve the symptoms of benign prostatic hyperplasia (BPH) of the drug. In order to verify its efficacy and safety, we conducted in March 1997 to May 40 cases of patients with insured forefront of BPH clinical observation. The report is as follows. 1 Materials and Methods 1.1 Case Information All cases were outpatients, aged 54 to 78 years (mean, 65 years). Before treatment, there are complaints of dysuria, the average duration of 4.3a. All patients had no other serious illness and no special treatment. 1.2 Methods 1.2.1 drug treatment 40 patients were insured forefront of Paul, qid, 2 tablets / time (0.25g / tablet) for a total of 4 weeks. Clinical and laboratory tests were performed before treatment and after 4 weeks of treatment, respectively. During treatment